Back to User profile » Dr Neil Clendeninn
Paper published by Dr Neil Clendeninn:
Original Research
Bioequivalence of HTX-019 (aprepitant IV) and fosaprepitant in healthy subjects: a Phase I, open-label, randomized, two-way crossover evaluation
Ottoboni T, Keller MR, Cravets M, Clendeninn N, Quart B
Drug Design, Development and Therapy 2018, 12:429-435
Published Date: 1 March 2018